Production (Stage)
Esperion Therapeutics, Inc.
ESPR
$1.17
-$0.03-2.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 114.63M | 144.76M | 144.72M | 189.30M | 226.61M |
| Total Receivables | 81.29M | 80.14M | 67.82M | 60.36M | 54.61M |
| Inventory | 99.32M | 94.49M | 80.10M | 84.47M | 73.10M |
| Prepaid Expenses | 23.53M | 18.60M | 14.91M | 10.98M | 11.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 318.78M | 338.00M | 307.56M | 345.11M | 365.61M |
|
|
|||||
| Total Current Assets | 318.78M | 338.00M | 307.56M | 345.11M | 365.61M |
| Net Property, Plant & Equipment | 5.20M | 5.77M | 6.50M | 7.16M | 7.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.00K | 56.00K | 56.00K | 56.00K | 56.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 324.03M | 343.82M | 314.11M | 352.32M | 373.06M |
|
|
|||||
| Total Accounts Payable | 71.99M | 51.65M | 34.86M | 47.67M | 28.43M |
| Total Accrued Expenses | 23.70M | 24.63M | 22.79M | 26.71M | 26.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 114.73M | 104.90M | 41.14M | 35.43M | 46.03M |
| Total Finance Division Other Current Liabilities | 60.55M | 65.05M | 67.08M | 65.52M | 63.87M |
| Total Other Current Liabilities | 60.55M | 65.05M | 67.08M | 65.52M | 63.87M |
| Total Current Liabilities | 270.97M | 246.23M | 165.87M | 175.34M | 164.51M |
|
|
|||||
| Total Current Liabilities | 270.97M | 246.23M | 165.87M | 175.34M | 164.51M |
| Long-Term Debt | 477.30M | 483.74M | 515.15M | 517.22M | 498.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.97M | 2.57M | 3.30M | 3.98M | 4.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 750.24M | 732.54M | 684.32M | 696.54M | 667.36M |
|
|
|||||
| Common Stock & APIC | 1.27B | 1.27B | 1.26B | 1.26B | 1.25B |
| Retained Earnings | -1.64B | -1.60B | -1.58B | -1.55B | -1.49B |
| Treasury Stock & Other | -55.00M | -55.00M | -55.00M | -55.00M | -55.00M |
| Total Common Equity | -426.21M | -388.72M | -370.21M | -344.22M | -294.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -426.21M | -388.72M | -370.21M | -344.22M | -294.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -426.21M | -388.72M | -370.21M | -344.22M | -294.30M |
|
|
|||||